How long does it take for infliximab to take effect?
Infliximab (Infliximab) is a biological agent, and its onset time is affected by multiple factors such as the patient's condition type, individual immune response, dosage and treatment cycle. Generally speaking, some patients can notice an improvement in symptoms within one to two weeks after the first dose, especially in diseases with obvious inflammatory reactions such as Crohn's disease (CD) or ankylosing spondylitis, where the effect is faster. In chronic diseases such as rheumatoid arthritis or psoriasis, the full effect of the drug usually appears gradually after about 6 weeks of medication, that is, after the second or third injection after completion of induction therapy.

Infliximab is administered by intravenous infusion, and its onset of action is relatively concentrated. The initial dosing schedule is one injection each at week 0, week 2, and week 6. This stage is called the "induction period", with the purpose of quickly controlling disease activity and reducing inflammatory response. After completing the induction period, most patients will enter the maintenance treatment period, with injections every 8 weeks to maintain stable disease and reduce the risk of recurrence. In clinical practice, if the patient does not show significant improvement after the first two doses, the doctor may adjust the dose based on actual evaluation or use it in combination with other immune drugs to improve the efficacy.
It should be particularly emphasized that the early efficacy of infliximab does not represent complete control of the disease. Its long-term effect depends on regular treatment, strict monitoring and individualized adjustment. Patients should avoid arbitrarily interrupting medication and have regular follow-up visits to detect inflammatory indicators and immune function. If there is no response for a long time or repeated failure, it is necessary to consider whether there is drug resistance or the production of antibodies. Taken together, although infliximab can quickly relieve symptoms, its optimal efficacy still requires time to accumulate and match the treatment strategy.
Reference materials:https://www.drugs.com/infliximab.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)